Quinone reductase 2 substrate specificity and inhibition pharmacology

This publication has 35 references indexed in Scilit:

• Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MT1 and MT2 receptors
  Biochemical Pharmacology, 2003
• New selective ligands of human cloned melatonin MT1 and MT2 receptors
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2003
• Therapeutic Perspectives for Melatonin Agonists and Antagonists
  Journal of Neuroendocrinology, 2003
• Disruption of Dihydronicotinamide Riboside:Quinone Oxidoreductase 2 (NQO2) Leads to Myeloid Hyperplasia of Bone Marrow and Decreased Sensitivity to Menadione Toxicity
  Published by Elsevier ,2002
• Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2
  Journal of Biological Chemistry, 2000
• Crystal Structure of Human Quinone Reductase Type 2, a Metalloflavoprotein^,
  Biochemistry, 1999
• Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase)
  Proceedings of the National Academy of Sciences, 1997
• Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2)
  Biochemical Pharmacology, 1992
• Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6
  Biochemistry, 1990
• Enzymatic oxidation of some non-phosphorylated derivatives of dihydronicotinamide
  Biochemical and Biophysical Research Communications, 1961